UBS Group AG - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$798,745
+63.8%
31,262
+83.9%
0.00%
Q2 2023$487,618
-50.6%
17,002
-58.7%
0.00%
Q1 2023$987,708
-31.6%
41,206
-51.6%
0.00%
-100.0%
Q4 2022$1,443,669
+2676.3%
85,122
+2346.0%
0.00%
Q3 2022$52,000
-91.0%
3,480
-90.6%
0.00%
Q2 2022$580,000
-89.4%
36,846
-81.8%
0.00%
-100.0%
Q1 2022$5,452,000
+48.8%
202,235
+104.2%
0.00%
+100.0%
Q4 2021$3,665,000
-14.5%
99,030
+10.3%
0.00%0.0%
Q3 2021$4,288,000
+273.2%
89,745
+164.2%
0.00%
Q2 2021$1,149,000
-35.0%
33,971
-20.6%
0.00%
-100.0%
Q1 2021$1,768,000
+44.9%
42,810
+52.2%
0.00%
Q4 2020$1,220,000
+104.4%
28,128
+102.0%
0.00%
Q3 2020$597,000
-19.7%
13,928
-12.3%
0.00%
Q2 2020$743,000
+24666.7%
15,888
+6280.7%
0.00%
Q1 2020$3,000
-50.0%
249
-55.3%
0.00%
Q4 2019$6,000
-78.6%
557
-80.9%
0.00%
Q2 2019$28,0002,9190.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders